Vystar Director Matthan to Unveil Major Advances in Ultra Low Protein Latices at International Latex Conference

ATLANTA, GA and AKRON, OH--(Marketwired - Aug 6, 2015) - Vystar Corp. (OTC PINK: VYST) Board of Directors Member and Research & Development Director Ranjit K. Matthan, Ph.D., will reveal ongoing developments in the formulation of Ultra Low Protein Latices (ULPL) with reduced or no ammonia and nitrosamines at the International Latex Conference session titled "Advances in Environmentally Friendly Ultra Low Protein Natural Rubber Specialty Latices" at 11:30 a.m., August 12th at the Hilton Akron/Fairlawn in Akron, Ohio. The significant advances in aluminum hydroxide-treated Ultra Low Protein Latices (ULPL) properties and applications are potential game-changers for the issues of volatile organic content and nitrosamines for some critical latex products, such as balloons, catheters, condoms, and other medical devices, as well as enabling cleaner and more sustainable work environments.

"In recent years, the latex industry has sought to reduce or eliminate the need for nitrosamines and ammonia in natural rubber latex to remove any potential health hazards for those with long term exposure in the production of natural rubber latex and in the manufacture of natural rubber latex products in several end use applications," stated Dr. Matthan. "These expanded Vystar product grades make it applicable in a wider range of latex products with the advantage of improved environmental impact through reduced leachables/extractables. These advances finally deliver a simplified, sustainable, totally safe raw material that Vystar can offer for several applications without reservations about nitrosamines."

Manufacturers and interested industry stakeholders desiring to schedule an appointment at the conference to discuss the advances with Dr. Matthan should contact Vystar at (866) 674-5238, x1 or email Info@vytex.com.

Dr. Matthan has worked closely with Joseph John, Director of the Polymer Consultancy Services Ltd, Chennai, India, and Bill Doyle, CEO of Vystar Corp., on the formulations R&D, and these developments will be presented at the conference.

Dr. Matthan has been associated with the development of natural rubber and rubber based industries manufacturing in South Asia since the 1970s and has contributed significantly to South Asia becoming the major player in the global rubber industry. He has advised national and international companies and research bodies as well as many leading private companies engaged in Natural Rubber and Latex production and manufacturing. Through the Bangkok-based Asia Pacific Elastomer Science and Technology (APEST), he has played a key role in creating awareness of the sustainability issues related to natural rubber. He has also been associated with the development and commercial introduction of several eco-friendly natural rubber grades, including Vytex NRL. Dr. Matthan has received two key industry awards, including: the prestigious biennial 2014 Institute of Materials, Minerals and Mining, U.K.'s Hancock Medal for his contributions to the development of the environmentally friendly sustainable growth of the global natural rubber industry, and the biennial 2006 KM Philip Award and Gold Medal from the All India Rubber Industries Assoc. for significant contributions toward the development of the Indian Rubber Industry.

About Vystar Corporation
Based in Atlanta, GA, Vystar® Corporation (OTC PINK: VYST) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows. Vystar's Kiron Sleep Lab LLC acquisition provides an entry into the health and wellness market. For more information, visit www.vytex.com.

Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward- Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.